CD226 and COVID-19: In our study with all patients being in a cytokine storm, in severe COVID‐19 patients, circulating MAIT cells showed a significant decrease in the expression of the activating immune checkpoint receptor CD226, whereas the frequency of TIGIT/PD‐1 double‐positive MAIT cells was significantly increased in severe patients compared to both healthy individuals and moderate patients.